Conference Coverage

New agent builds bone bigger, faster


 

AT ICE/ENDO 2014

References

These phase II studies were funded by Radius Health.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Nonmelanoma skin cancer linked to increased fracture risk in postmenopausal women
MDedge Endocrinology
VIDEO: Less frequent zoledronic acid is safe, retains efficacy
MDedge Endocrinology
Denosumab's benefits persist through 8 years
MDedge Endocrinology
Effects of IV bisphosphonates last 2-3 years in children
MDedge Endocrinology
Effects of IV bisphosphonates last 2-3 years in children
MDedge Endocrinology
Monitor elderly for bone loss after gastric bypass
MDedge Endocrinology
Monitor elderly for bone loss after gastric bypass
MDedge Endocrinology
Hyponatremia linked to osteoporosis, fragility fractures
MDedge Endocrinology
Meta-analysis finds limited bone loss with low-dose glucocorticoids
MDedge Endocrinology
Fractures increased with two diabetes drugs
MDedge Endocrinology